D. Ionescu

发表

Pharmaceutical development of IPI‐504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer

Denise A. Mayes, G. Sylvester, J. Adams, 2010 .

Pharmaceutical Development of IPI-504, an Aqueous Soluble Analog of 17-AAG and Potent Inhibitor of Hsp90

G. Sylvester, E. Holson, J. Helble, 2008 .

Peptide Coupling in the Presence of Highly Hindered Tertiary Amines

A. El‐Faham, L. A. Carpino, D. Ionescu, 1996 .

The 1,1-Dioxobenzo[b]thiophene-2-ylmethyloxycarbonyl (Bsmoc)† Amino-Protecting Group

A. El‐Faham, R. Warrass, M. Ismail, 1999 .

New Family of Base- and Nucleophile-Sensitive Amino-Protecting Groups. A Michael-Acceptor-Based Deblocking Process. Practical Utilization of the 1,1-Dioxobenzo[b]thiophene-2-ylmethyloxycarbonyl (Bsmoc)† Group

M. Weiss, A. El‐Faham, R. Warrass, 1997 .

Protected amino acid chlorides vs protected amino acid fluorides: Reactivity comparisons.

H. Wenschuh, A. El‐Faham, M. Beyermann, 1998 .

Fmoc amino acid fluorides in peptide synthesis - Extension of the method to extremely hindered amino acids

H. Wenschuh, M. Beyermann, M. Bienert, 1996 .

LDA-induced metalation of isoindolinones. An efficient route to 3-substituted isoindoline derivatives

A. Couture, E. Deniau, P. Grandclaudon, 1998 .

A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agents.

E. Novellino, T. Rauen, G. Campiani, 2001, Journal of medicinal chemistry.

On the use of novel coupling reagents for solid-phase peptide synthesis

F. Albericio, A. El‐Faham, L. Herman, 1996 .

Complex polyfluoride additives in Fmoc-amino acid fluoride coupling processes. Enhanced reactivity and avoidance of stereomutation.

H. Wenschuh, P. Henklein, A. El‐Faham, 2003, Organic letters.

Protected amino acid chlorides: Coupling reagents suitable for the most highly hindered systems

H. Wenschuh, A. El‐Faham, M. Beyermann, 2002 .

1,1-Dioxonaphtho[1,2-b]thiophene-2-methyloxycarbonyl (α-Nsmoc) and 3,3-Dioxonaphtho[2,1-b]thiophene-2-methyloxycarbonyl (β-Nsmoc) Amino-Protecting Groups†

L. A. Carpino, E. Mansour, D. Ionescu, 2007 .

Rapid, continuous solution-phase peptide synthesis: Application to peptides of pharmaceutical interest

B. Morgan, M. Ismail, L. A. Carpino, 2003 .

A New Process for Antineoplastic Agent Clofarabine

William Bauta, J. Puente, Brian Burke, 2004 .

Stereochemistry and mechanisms of thermal cycloaddition reactions of conjugated enynes. The stereospecific formation of six tetrahedral centers in a single reaction

B. Miller, L. Dickinson, J. Silverton, 1996 .

Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain.

I. Niculescu-Duvaz, V. Dobre, D. Ionescu, 1978, Journal of medicinal chemistry.